We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Prospective Study Comparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies Versus Pregnancies Complicated by Placental Abnormalities

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2007 by Rady Children's Hospital, San Diego.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00490607
First Posted: June 25, 2007
Last Update Posted: June 25, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rady Children's Hospital, San Diego
  Purpose
The purpose of this study is to investigate the pathogenesis of hemangiomas of infancy as they relate to normal pregnancies and those pregnancies complicated by placenta abnormalities. Women of all gestational ages will be enrolled in the study. Maternal serum, placental, and cord blood samples will be obtained for each subject. A medical history will be obtained for each subject. Post-delivery a member of the study team will perform a cutaneous exam of the infant to establish what birthmarks are present at birth. Mother will receive four phone call follow ups to determine if the infant has had any skin changes. If yes, mother will be asked to bring the child in for evaluation. If a hemangioma is diagnosed, a blood draw will be performed.

Condition
Hemangioma

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Rady Children's Hospital, San Diego:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • pregnant women delivering at Sharp Mary Birch Hospital for Women in San Diego, CA
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00490607


Locations
United States, California
Sharp Mary Birch Hospital for Women Recruiting
San Diego, California, United States
Contact: Andrea M Munden, BS    858-576-1700 ext 5210    amunden@rchsd.org   
Sponsors and Collaborators
Rady Children's Hospital, San Diego
Investigators
Principal Investigator: Sheila F Friedlander, MA Rady Children's Hospital, San Diego
  More Information

ClinicalTrials.gov Identifier: NCT00490607     History of Changes
Other Study ID Numbers: Hemangioma Study
First Submitted: June 21, 2007
First Posted: June 25, 2007
Last Update Posted: June 25, 2007
Last Verified: June 2007

Keywords provided by Rady Children's Hospital, San Diego:
Hemagiomas of infancy

Additional relevant MeSH terms:
Hemangioma
Neoplasms, Vascular Tissue
Neoplasms by Histologic Type
Neoplasms